Method using a new calibrator and a device and test kit including the calibrator

• US 6,916,666 B1
• Filed: 12/30/1998
• Issued: 07/12/2005
• Est. Priority Date: 12/30/1997
• Status: Expired due to Term

• Current Assignee: Phadia AB (Thermo Fisher Scientific Incorporated)
• Original Assignee: Pharmacia Diagnostics AG
• Inventors: Mendel-Hartvig, Ib, Gustafsson, Jörgen
• Primary Examiner(s): Le, Long V.
• Assistant Examiner(s): Counts, Gary W.
• Application Number:
  US09/582,741
• Time in Patent Office: 2,386 Days
• Field of Search: 435/7.1, 435/7.92, 435/7.93, 435/7.94, 435/287.1, 435/287.7, 435/287.9, 436/501, 436/518, 436/523, 436/831, 436/514, 436/169, 436/808, 422 56- 58
• US Class Current: 436/518
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387

Abstract

A lateral flow method for the determination of an analyte in a sample utilizes biospecific affinity reactions. The method comprises forming a complex comprising Reactant I - - - Analyte′ - - - Reactant* wherein Reactant* and Reactant I exhibit biospecific affinity to the analyte, Reactant* is analytically detectable, and Analyte′ is the analyte or an analyte-related reactant, determining a detectable signal from Reactant* in the complex (sample value), and obtaining the amount of analyte in a sample by comparing the sample value with one or more calibrator values, each of which corresponds to a standard amount of analyte. Before determination of the calibrator value, either calibrator or a binder for the calibrator has been bound to a matrix and is released at the determination of calibrator value. The calibrator and the analyte have the ability to biospecifically bind to Reactant* via equivalent binding sites, and one or more calibrator zones comprising calibrator or binder for the calibrator are located in the same process flow as Reactant I in a detection zone. A device for transforming measured signal values for a completed, analytically detectable reactant (Reactant*) to real amounts of analyte in a sample comprises a flow matrix in which there is an area of process flow for the transport of Reactant*, having one or more calibrator zones, an application zone for Reactant* upstream of the one or more calibrator zones, and one or more detection zones downstream of the one or more calibrator zones.

Claims

1. A lateral flow method for the determination of an analyte in a sample involving utilizing biospecific affinity reactions, and comprising the following steps:

i. forming a complex in a lateral flow matrix, the complex comprising;

Reactant I - - - Analyte′

- - - Reactant*, where

a. Reactant* and Reactant I exhibit biospecific affinity to the analyte,

b. Reactant* is analytically detectable,

c. Analyte′

is the analyte or an analyte-related reactant, and subsequently

ii. determining the detectable signal constituting a sample value from Reactant* in the complex, and

iii. determining the amount of analyte in the sample by comparing the sample value with one or more calibrator values, each of which corresponds to a standard amount of analyte,

wherein A) before determination of the calibrator value, either (i) calibrator, or (ii) a binder for the calibrator has been bound to a matrix, and when a binder for the calibrator has been bound to the matrix, calibrator is added or calibrator predeposited in the matrix is released for binding with the binder, and the matrix is insoluble in the liquid medium in which binding of Reactant* to the calibrator occurs, B) the calibrator and the analyte exhibit biospecific affinity to Reactant* by equivalent binding sites, C) two or more calibrator zones CZ comprising calibrator or binder for the calibrator are located in a single process flow stream with Reactant I in a detection zone (DZ), and D) all of the detection zones DZ are downstream of all of the calibrator zones CZ in the lateral flow matrix.

2. The method according to claim 1, wherein calibrator has been bound to the matrix before the determination of calibrator value.

3. The method according to claim 1, wherein a binder for the calibrator has been bound to the matrix before the determination of calibrator value.

4. The method according to claim 1, wherein the binder for the calibrator is one member of a specific binding pair, and the other member of the specific binding pair is coupled or conjugated to the calibrator.

5. The method according to claim 1, wherein

a. (i) each calibrator zone comprises calibrator in an amount corresponding to a standard amount of analyte, or

(ii) each calibrator zone contains calibrator binder, the amount of calibrator binder and the amount of calibrator corresponding to a standard amount of analyte, and

b. Reactant* is bound to the calibrator by transporting Reactant* through the calibrator zones.

6. The method according to claim 1, wherein along a single matrix is the flow matrix, and wherein along a single process flow stream, there are

a. two or more calibrator zones (CZ), each of which exhibits a matrix calibrator or a matrix calibrator binder,

b. one or more detection zones (DZ), in which a Capturer is firmly anchored and is either Reactant I or a biospecific affinity reactant, which directly or indirectly binds Reactant I biospecifically,

c. an application zone for Reactant*, A_R*Z, which is located upstream of said CZ and DZ and to which Reactant* is optionally predeposited, and

d. an application zone for sample (A_SZ) which is located

i. upstream of or coinciding with a detection zone,

ii. downstream or upstream of or coinciding with A_R*Z(A_SZ/A_R*Z), or

iii. upstream of, downstream of or coinciding with a calibrator zone,

wherein Reactant* is added to A_R*Z if Reactant* is not predeposited, or buffer is added to A_R*Z if Reactant* is predeposited, and sample is added to A_SZ, optionally premixed with Reactant* if A_SZ and A_R*Z coincide, such that analyte and Reactant* reach DZ at the same time, or such that analyte reaches DZ before Reactant*.

7. The method according to claim 6, wherein the calibrator zones CZ comprise a calibrator binder, and calibrator is predeposited upstream of the calibrator zones.

8. The method according to claim 6, wherein the process flow stream comprises two of said calibrator zones, and the level of analyte in the sample is obtained by:

a. comparing a calibrator value from one of the calibrator zones located in the process flow stream including the detection zone, with one or more separately obtained calibrator values to determine a deviation between the measured calibrator value and the separately obtained calibrator values, and

b. adjusting the sample value from the detection zone by the deviation, and subsequently obtaining the level of analyte in the sample by comparing the adjusted sample value with one or more of the separately obtained calibrator values.

9. The method according to claim 6, wherein

a. A_SZ is (i) common to A_R*Z, forming a common zone A_SZ/A_R*Z or (ii) is located upstream of A_R*Z, and

b. for alternative (i) sample is premixed with Reactant* before it is added to the common zone A_SZ/A_R*Z, or sample is added to the common zone A_SZ/A_R*Z containing predeposited Reactant*, or for alternative (ii), sample is added to A_SZ, which is located upstream of A_R*Z which in turn comprises predeposited Reactant*.

10. The method according to claim 5, wherein Reactant* has particles as an analytically detectable group, and/or calibrator or calibrator binder is/are anchored to the matrix by particles.

11. The method according to claim 1, wherein the analyte is an antibody directed to Reactant I or to Reactant*, and

a. Reactant* is an antibody directed to the analyte and Reactant I is an antigen or hapten, when the analyte is an antibody directed to Reactant I, or

b. Reactant* is an antigen or a hapten and Reactant I is an antibody directed to the analyte, when the analyte is an antibody directed to Reactant*.

12. The method according to claim 1, wherein the analyte is an antigen, and Reactant* and Reactant I are antibodies directed to the analyte.

13. The method according to claim 1, wherein the method is performed as a part of diagnosing allergy or autoimmune disease.

26. The method according to claim 1, wherein Reactant* comprises a fluorophore group or a chromogenic group.

27. The method according to claim 1, wherein Reactant* comprises metal particles or nonmetal particles.

28. The method according to claim 1, wherein Reactant* comprises gold sol particles.

14. A device for transforming measured signal values of a complexed, analytically detectable reactant (Reactant*) to real amounts of analyte in a sample, in connection with performing an analysis method which utilizes biospecific affinity reactions for the determination of the amount of analyte in a sample, wherein the device comprises:

a flow matrix in which there is an area of process flow for the transport of Reactant*, and wherein there are in said area

i. two or more calibrator zones (CZ) comprising a calibrator, or binder for the calibrator, which is firmly anchored to the matrix, the amounts of calibrator or calibrator binder, respectively, being different for at least two calibrator zones and the calibrator exhibiting binding sites to which Reactant* binds, when Reactant* is transported through a calibrator zone,

ii. an application zone for Reactant* (A_R*Z) upstream of said calibrator zones, and

iii. one or more detection zones (DZ), all of the detection zones being downstream of all of the calibrator zones.

15. The device according to claim 14, wherein a calibrator binder is firmly anchored in the matrix and the device comprises calibrator predeposited upstream of the calibrator zones.

16. The device according to claim 14, wherein the device comprises Reactant* predeposited in A_R*Z.

17. The device according to claim 14, wherein the process flow comprises a detection zone (DZ) which is located downstream of A_R*Z and comprises a firmly anchored Capturer to which Reactant* can bind in the DZ, and a zone of application of sample (A_SZ) which is located upstream of or coincides with said DZ.

18. The device according to claim 17, wherein A_R*Z is located upstream of or downstream of or coincides with A_SZ.

19. The device according to claim 17, wherein the firmly anchored reactant (Capturer) has biospecific affinity to the analyte or to an analyte-related reactant.

20. The device according to claim 17, wherein the firmly anchored reactant (Capturer) has biospecific affinity to a second reactant which in turn has biospecific affinity to the analyte or to an analyte-related reactant.

21. The device according to claim 17, wherein A_SZ is located upstream of all calibrator zones.

22. A test kit, comprising a device according to claim 14.

23. The kit according to claim 22, wherein the kit comprises Reactant*.

24. The kit according to claim 22, wherein the kit comprises calibrator when said device has the calibrator binder bound to the matrix.

25. The device according to claim 14, wherein Reactant* has biospecific affinity to analyte or an analyte-related reactant and to the calibrator.

29. The device according to claim 14, wherein Reactant* comprises a fluorophore group or a chromogenic group.

30. The device according to claim 14, wherein Reactant* comprises metal particles or nonmetal particles.

31. The device according to claim 14, wherein Reactant* comprises gold sol particles.